We recommend Drojust M instead of Helpas. Exact salt composition from top brand
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothDrotaverine 80mg + Mefenamic Acid 250mg
Salt CompositionDrotaverine 80mg + Mefenamic Acid 250mg (same for both)
Helpas 80mg/250mg Tablet
You Searched
Helpas 80mg/250mg Tablet
H.L Healthcare Pvt. Ltd.
Helpas 80mg/250mg Tablet
H.L Healthcare Pvt. Ltd.
₹69
Our Recommendation
Drojust M 80/250mg Tablet 10s
Dr. Morepen Ltd.
2,340+ Customers trust this
WHO GMP Certified
Assured by
Assured
Drojust M 80/250mg Tablet 10s
Assured by
Assured
2,340+ trust this
WHO GMP Certified
Customers also bought
More About Helpas
Benefits
In Treatment of Abdominal pain Helpas 80mg/250mg Tablet effectively relieves sudden muscle spasms or contractions in the stomach and intestine (gut), thereby relaxing the muscles and improving movement of food. It also blocks chemical messengers in the brain that are responsible for pain sensation. This helps to treat abdominal pain (or stomach pain) as well as cramps, bloating and discomfort. Take Helpas 80mg/250mg Tablet as prescribed by the doctor. Eventually, it will help you to go about your daily activities more easily and have a better, more active, quality of life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Helpas 80mg/250mg Tablet is to be taken with food.
How it works
Helpas 80mg/250mg Tablet is a combination of two medicines: Drotaverine and Mefenamic Acid, which relieves abdominal pain and cramps. Drotaverine is an anti-spasmodic medicine which relieves contractions (spasms) associated with smooth muscles in the abdomen. Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID). It works by blocking the release of certain chemical messengers that cause abdominal pain and inflammation (swelling).
Unsafe: Avoid consuming alcohol with Helpas 80mg/250mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Helpas 80mg/250mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Helpas 80mg/250mg Tablet during breastfeeding is not available. Doctor consultation is advised.
Not Safe: Helpas 80mg/250mg Tablet may cause side effects which could affect your ability to drive. As Helpas 80mg/250mg Tablet may cause vertigo.
Caution Advised: Helpas 80mg/250mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Helpas 80mg/250mg Tablet may be needed. Doctor consultation is advised. Use of Helpas 80mg/250mg Tablet is not recommended in patients with severe kidney disease.
Caution Advised: Helpas 80mg/250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Helpas 80mg/250mg Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Helpas 80mg/250mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
SCF-320, 1ST FLOOR, MOTOR MARKET, MANIMAJRA, CHANDIGARH-160101 (UT)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
